Document is current

Any future updates will be listed below

Correction to: Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities

Crossref DOI link: https://doi.org/10.1007/s00277-020-04288-9

Published Online: 2020-09-26

Published Print: 2020-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark